维普期刊资源整合服务平台（V6.5）

161篇 您的检索式：作者名="GIOVANNETTI E"

选中清除导出查看参考文献查看引证文献引用追踪共9页首页上一页第1页下一页末页 /9 跳转

	题名	作者	年代	出处	被引量
1	Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometry显示文摘	Honeywell R Yarzadah K Giovannetti E	2010	J Chromatogr B Analyt Technol Biomed Life Sci2010，878，1516：	1
2	MicroRNA-21 in pancreatic cancer:correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity显示文摘	Giovannetti E Funel N Peters G J Del Chiaro M Erozenci LA Vasile E		0，，：	1
3	Soil-carpophore in some Italian truffle edo-environm ents显示文摘	Zanini E Giovannetti G Franchini N etal	1995	AgricoItura Mediterranea1995，125，：	1
4	Pharmacogenetic study of patients with advanced non-small cell lung cancer(NSCLC)treated with second-line pemetrexed or pemetrexed-carboplatin显示文摘	Tiseo M Giovannetti E Tibaldi C	2012	Lung Cancer2012，78，1：	1
5	Thymidylate synthase inhibitors for non-small cell lung cancer显示文摘	Galvani E Peters G J Giovannetti E		0，，10：	1
6	Critical role of lasermicrodissection for genetic,epigenetic and proteomic analysesin pancreatic cancer显示文摘	Funel N Giovannetti E Pollina LE	2011	Expert Rev Mol Diagn2011，11，7：	1
7	Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine 显示文摘	Giovannetti E Del Taeca M Mey V etal	2006	Cancer Res2006，66，7：	1
8	Cellular and pharma cogenetics foundation of synergistic interaction of pemetrexed and gemcitabine in human non-small cell lung cancer cells显示文摘	Giovannetti E Mey V Nannizzi S	2005	Mol Pharmacol2005，68，1：	1
9	Cellular and pharmacogenetics foundation of synergistic interaction ofpemetrexed and gemcitabine in human non-small-cell lung cancer cells 显示文摘	Giovannetti E Mey V Nannizzi S	2005	Mol Pharmacol2005，68，：	1
10	Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer显示文摘	Hwang J H Voortman J Giovannetti E	2010	PLoS One2010，5，10：	1
11	Impact of ABCG2 polymorphisms on the clinical outcome and tox- icity of gefitinib in non-small-cell lung cancer patients显示文摘	Lemos C Giovannetti E Zucali PA	2011	Pharmacogenomics2011，12，2：	1
12	USP1 deubiquitinase:cellular functions,regulatory mechanisms and emerging potential as target in cancer therapy显示文摘	Garcia-Santisteban I Peters GJ Giovannetti E	2013	Mol Cancer2013，12，：	1
13	Impact of cytidine deaminase polymorphisms on toxicity after gemcitabine:The question is still ongoing显示文摘	Giovannetti E Tibaldi C Falcone A	2010	J Clin Oncol2010，28，14：	1
14	MicroRNA-21 in pancreatic cancer:correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity显示文摘	Giovannetti E Funel N Peters GJ		0，，：	1
15	Thymidy- late synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed/carboplatin 显示文摘	Zucali P A Giovannetti E Destro A	2011	Clini- cal Cancer Research2011，17，8：	1
16	Inherited germline T790M mutation and somatic epidermal growth factor re- ceptor mutations in non-small cell lung cancer patients显示文摘	Tibaldi C Giovannetti E Vasile E	2011	J Thorac Oncol2011，6，2：	1
17	Pharmacogenetics of anticancer drug sensitivity in pancreatic cancer 显示文摘	Giovannetti E Mey V Nannizzi S	2006	Mol Cancer Ther2006，5，6：	1
18	Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer 显示文摘	Hwang JH Voortman J Giovannetti E	2010	PLoS One2010，5，10：	1
19	c-Met as a target for personalized therapy 显示文摘	Garajovli I Giovannetti E Biasco G	2015	Transl Oncogenomics2015，7，1：	1
20	Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non- small cell lung cancer cells 显示文摘	Tekle C Giovannetti E Sigmond J	2008	Br J Cancer2008，99，：	1

返回顶部每页显示：

共9页首页上一页第1页下一页末页 /9 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示